22 октябр 2019
2БИОЛОГИК ФАОЛ ҚЎШИМЧА «DEFIZINC»НИ ТОКСИКЛИГИНИ БАҲОЛАШ
20191022052753_Farmvest....pdf
MAQOLA ANNOTATSIYASI
MUALIFLAR
Teglar
Maqolani baholang
0
Maqola idintifikatorlari
DOI:
Mavjud emas
Foydalanilgan adabiyotlar
1. Ступень Е.Г., Коваленко В.В., Артемук Е.Г. Биологически активные соединения. //Сбор. Статей универ. Студ. Науч-практ. Конф. – Брест, -2016, -С. 95.
2. Livingstone C. Zinc: physiology, deficiency, and parenteral nutrition.//NutrClinPract.- 2015. №3. –С. 371-382.
3. Wong CP, Rinaldi NA, Ho E. Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation.//MolNutr Food Res. -2015; -№59: -С. 991-999.
4. Higashi Y, Aratake T, Shimizu S, Shimizu T, Nakamura K, Tsuda M, Yawata T, Ueba T3 , Saito M. Influence of extracellular zinc on M1 microglial activation.//Sci Rep.-2017; №7: -С. 437-478.
5. Tarushi A, Kakoulidou C, Raptopoulou CP, Psycharis V, Kessissoglou DP, Zoi I, Papadopoulos AN, Psomas G. Zinc complexes of diflunisal: Synthesis, characterization, structure, antioxidant activity and in vitro and in silico study of the interaction with DNA and albumins.//J InorgBiochem.-2017; -№170: -С. 85-97.
6. Santucci NR, Alkhouri RH, Baker RD, Baker SS. Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease. //J. PediatrGastroenterolNutr-2014; -№59. –С. 455-457.
7. Weisshof R., Chermesh I. Micronutrient deficiencies in inflammatory bowel disease.//CurrOpinClinNutrMetab Care -2015; - №18. –С.576-581.
8. Жаворонкова A.M., Мугинова С.В., Шеховцова Т.Н. Определение микроколичеств цинка (II) по реактивации апоферментов щелочных фосфатаз различного происхождения//Журн. аналитхимии. -2003 -№6. -С.658-665.
9. Finney LA, O'Halloran TV. Transition metal speciation in the cell: insights from the chemistry of metal ion receptors.//Science. -2003. -№30. –С. 931–936.
10. Igic PG, Lee E, Harper W, Roach KW. Toxic effects associated with consumption of zinc.//Mayo Clin Proc.-2002.-№77. -С.713–716.
11. Religa D, Strozyk D, Cherny RA, Volitakis I, Haroutunian V, et al. Elevated cortical zinc in Alzheimer disease. //Neurology. -2006. -№67. -С. 69–75.
12. Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration.//J Alzheimers Dis. -2006. -№10. -С.223–253.
13. Priel T, Aricha-Tamir B, Sekler I. Clioquinol attenuates zinc-dependent beta-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in mice.//Eur J Pharmacol. -2007. - №565. -С. 232–239.
14. Хабриев Р.У. Методические указания по изучению общетоксического действия фармакологических веществ.//Руково дство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М., 2005.